Significant drug interaction is now being reported between oral contraceptives and Rezulin (troglitazone)
August 1997
A significant drug interaction is now being reported between oral contraceptives and Rezulin (troglitazone).
Rezulin is the brand new diabetes drug from Parke-Davis. It just came out in the U.S...and will be launched soon in Canada. Rezulin increases insulin sensitivity in type 2 diabetics.
The problem is that Rezulin is an enzyme inducer...similar to phenobarbital and other anticonvulsants.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote